Kinematics of Silastic Joint Replacements in the Hand
Defining in Vivo Kinematics of Single Piece Silastic Joint Replacements in the Hand With Magnetic Resonance Imaging
Intervention / Treatment
Proximal inter phalangeal joint (PIPJ) replacement is performed for pain relief in the end stage of arthritis. Rheumatoid arthritis is the commonest indication in the metacarpophalangeal joint (MCPJ). In the PIPJ there is a more even spilt between degenerative and rheumatoid arthritis.
There are several options for PIPJ replacement currently licensed for use in the United Kingdom although data is not entered in to the National Joint Registry so the exact numbers and failure rates are unknown. Data from the Norwegian joint registry indicates that 99% of implanted MCPJ and PIPJ replacements are single piece silastic implants.
Three main prostheses represent the majority of implants used in the United Kingdom, Swanson, Sutter and Neuflex. All these implants have been shown in the literature to fracture either at the hinge or the distal stem - hinge interface. This is true of explants and in vitro simulator testing.
Long term survivorship in MCPJ and PIPJ replacement is below that of hip and knee replacement. One of the largest single series shows 63% survivorship at 17 year follow up but with radiological evidence of failure in at least two thirds. This compares poorly to the 82.9% survivorship for Exeter cemented hip replacements at 22 years. The long term aim of this project is to understand how the implants move. This will help explain failure in particular the newly observe hinge failure in Neuflex implants and provide ideas to improve these implants. Any modifications can be tested on the in vitro finger joint testing rig The method of MRI acquisition will be similar to that described in. This will require optimising. In order to limit movement to a sagittal displacement, a thermoplastic splint will support the wrist and hand up to the level of the proximal palmer crease. A rig will also be made to hold the MCP / PIP joints in extension and positions of flexion increasing by 200 to maximum flexion. These will depend upon the patient's range of motion. The Investigators will define the centre of rotation of the hinge then points on the shoulder and stem of the implant from which to measure displacement. Points on the metacarpal and proximal phalanx will also be defined to allow measurement of the displacement of the implant relative to the bone during the range of movement.
Contacts and Locations
- Name: Ian Trail
- Phone Number: 01257 488229
- Email: [email protected]
Wigan, United Kingdom, WN6 9EP
- Wrightington, Wigan & Leigh Teaching Hospitals NHS Foundation Trust
- Ian Trail
- Phone Number: 01257 567204
- Email: [email protected]
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
- Single piece silastic joint replacement with an adequate range of movement (ROM), i.e.
an arc of movement of ≥ 50
- Age over 18
- Able to give informed consent
- Any contraindication to MRI scanning
- Fractured implant
- Fixed flexion deformity >30 degrees in the replaced joint
- Total range of motion <50 degrees in the replaced joint
- Awaiting further surgery
- Abnormal joint instability
- Previous surgery on the same digit (other than the joint replacement)
- Replacement of the joint of the opposite hand
How is the study designed?
What is the study measuring?
Primary Outcome Measures
Deformation Assesment - Assesment of deformation of single piece silastic joint replacements in vivo
Time Frame: Six months
Currently the only studies of single piece silastic joint replacement movements are in cadaveric models. These have shown there is a difference in the instantaneous centre of rotation between replacement and native joints. This has not been shown in vivo. As stated in the rational of the study the issue to address is the high failure rate of single piece silastic joint replacements in the hand. Key to this is understanding how they behave in vivo and how this differs from native joints. The primary objective is to show that in vivo displacement can be shown with MRI and is a reproducible method. Once the MRI scans have been obtained a computer generated 3D model of the scans will be made and measurements of deformation of the implant and its movements relative to the bony supporting structure will be made.
Secondary Outcome Measures
To compare the movement of different implant designs and single replacements with native joints in combination with the assesment of acceptability and feasibility of MRI.
Time Frame: Through study completion, an average of one year
As this is an observational study there is no endpoint set other than the completed acquisition of the MRI sequences and the measurement of PROMS for each patient in the form of the patient rated wrist evaluation score and the quick disability of arm, shoulder and hand score.
Through study completion, an average of one year
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Arthritis
NCT05879419RecruitingRheumatoid Arthritis | Systemic Lupus Erythematosus | Systemic Sclerosis | Juvenile Idiopathic Arthritis | Sjogren's Syndrome | Spondylitis, Ankylosing | Spondyloarthritis | Idiopathic Inflammatory Myopathies | Vasculitis, Systemic | Dermatomyositis, Juvenile
NCT05862584Not yet recruitingRheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis
NCT05859997RecruitingSjogren's Syndrome | Antiphospholipid Syndrome | Systemic Lupus Erythematosus (SLE) | ANCA Associated Systemic Vasculitis | Inflammatory Myopathy | Diffuse Scleroderma
NCT05835895Not yet recruitingSafety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis (DONATELLO)Joint Diseases | Musculoskeletal Diseases | Osteoarthritis | Knee Osteoarthritis | Osteoarthritis, Knee | Osteo Arthritis Knee | Inflammatory Arthritis | Knee Arthritis | Knee Pain Chronic | Arthritis Knee
NCT05833360Not yet recruitingDepression | Heart Failure | Kidney Cancer | Hypertension | Diabetes | Breast Cancer | Chronic Kidney Diseases | Arthritis | Hepatitis | Inflammatory Bowel Diseases
NCT05795543Not yet recruitingSubtalar Osteoarthritis Secondary to Inflammatory Arthritis
NCT05796245Not yet recruitingA Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisArthritis, Rheumatoid | Psoriasis | Crohn Disease | Colitis, Ulcerative
NCT05759585Not yet recruiting
NCT05723406RecruitingThe Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study (MAGIC)Osteoarthritis, Hip | Innate Inflammatory Response